Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis

Cardiovascular Research

Volumn 86, Issue 2, 2010, Pages 330-337

  Madrigal Matute, Julio ^a   López Franco, Oscar ^a   Blanco Colio, Luis Miguel ^a   Muñoz García, Begoña ^a   Ramos Mozo, Priscila ^a   Ortega, Luis ^b   Egido, Jesus ^a   Martín Ventura, Jose Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Atherosclerosis; Heat shock proteins; Inflammation

Indexed keywords

17 DEMETHOXY 17 (2 DIMETHYLAMINOETHYLAMINO)GELDANAMYCIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT PROTEIN; TANESPIMYCIN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

AGED; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BENZOQUINONES; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LACTAMS, MACROCYCLIC; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; STAT TRANSCRIPTION FACTORS;

EID: 77951680995     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq046     Document Type: Article

References (37)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997;349:1269-1276.
2. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275. (Pubitemid 30262927)
3. Redgrave JN, Gallagher P, Lovett JK, Rothwell PM. Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study. Stroke 2008;39:1722-1729.
4. Mart́in-Ventura JL, Blanco-Colio LM, Muñoz-Garćia B, Gó mez-Hernández A, Arribas A, Ortega L et al. NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability. Stroke 2004;35:458-463. (Pubitemid 38174430)
5. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 2003;228: 111-133. (Pubitemid 36187918)
6. Zhang H, Burrows F. Targeting multiple signal transduction pathways through inhibition of Hsp90. J Mol Med 2004;82:488-499. (Pubitemid 39149859)
7. Adhikari N, Charles N, Lehmann U, Hall JL. Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury. Curr Atheroscler Rep 2006;8:252-260. (Pubitemid 43676330)
8. Blanco-Colio LM, Tuñón J, Martin-Ventura JL, Egido J. Antiinflammatory and immuno-modulatory effects of statins. Kidney Int 2003;63:12-23.
9. López-Franco O, Hernández-Vargas P, Ortiz-Muñoz G, Sanjuán G, Suzuki Y, Ortega L et al. Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2006;26:1864-1870. (Pubitemid 44305342)
10. Ortiz-Muñoz G, Martin-Ventura JL, Hernandez-Vargas P, Mallavia B, Lopez-Parra V, Lopez-Franco O et al. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29:525-531.
11. Malhotra V, Shanley TP, Pittet JF, Welch WJ, Wong HR. Geldanamycin inhibits NF-kappaB activation and interleukin-8 gene expression in cultured human respiratory epithelium. Am J Respir Cell Mol Biol 2001;25:92-97. (Pubitemid 32682710)
12. Wax S, Piecyk M, Maritim B, Anderson P. Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcripts. Arthritis Rheum 2003;48:541-550. (Pubitemid 36278024)
13. Dello Russo C, Polak PE, Mercado PR, Spagnolo A, Sharp A, Murphy P et al. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyeli-tis. J Neurochem 2006;99:1351-1362. (Pubitemid 44733930)
14. Chatterjee A, Dimitropoulou C, Drakopanayiotakis F, Antonova G, Snead C, Cannon J et al. Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis. Am J Respir Crit Care Med 2007; 176:667-675. (Pubitemid 47503074)
15. Poulaki V, Iliaki E, Mitsiades N, Mitsiades CS, Paulus YN, Bula DV et al. Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis. FASEB J 2007;21: 2113-2123. (Pubitemid 47026447)
16. Moreno JA, Muñoz-Garćia B, Mart́in-Ventura JL, Madrigal-Matute J, Orbe J, Páramo JA et al. The CD163-expressing macrophages recognize and internalize TWEAK. Potential consequences in atherosclerosis. Atherosclerosis 2009;207:103-110.
17. Mart́in-Ventura JL, Madrigal-Matute J, Muñoz-Garcia B, Blanco-Colio LM, Van Oostrom M, Zalba G et al. Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells. Cardiovasc Res 2009;83:586-594.
18. Wasserman BA, Wityk RJ, Trout HH 3rd, Virmani R. Response to Letter by Karapa-nayiotides et al. Stroke 2006;37:1647.
19. Lang SA, Klein D, Moser C, Gaumann A, Glockzin G, Dahlke MH et al. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Mol Cancer Ther 2007;6:1123-1132. (Pubitemid 46554583)
20. Hollingshead M, Alley M, Burger AM, Borgel S, Pacula-Cox C, Fiebig H et al. In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17- demethoxygelda-namycin hydrochloride), a water-soluble geldanamycin derivative. Cancer Chemother Pharmacol 2005;56:115-125. (Pubitemid 40884267)
21. Sausville EA, Tomaszewski JE, Ivy P. Clinical development of 17-allylamino, 17-demethoxygeldanamycin. Curr Cancer Drug Targets 2003;3:377-383. (Pubitemid 37128324)
22. Kaartinen M, Penttilä A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994;90:1669-1678. (Pubitemid 24320913)
23. Mart́in-Ventura JL, Ortego M, Esbrit P, Hernández-Presa MA, Ortega L, Egido J. Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis. Stroke 2003;34:1783-1789. (Pubitemid 36842646)
24. Businaro R, Profumo E, Tagliani A, Buttari B, Leone S, D'Amati G et al. Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis 2009;207:74-83.
25. Sõti C, Nagy E, Giricz Z, V́igh L, Csermely P, Ferdinandy P. Heat shock proteins as emerging therapeutic targets. Br J Pharmacol 2005;146:769-780. (Pubitemid 41622243)
26. Rice JW, Veal JM, Fadden RP, Barabasz AF, Partridge JM, Barta TE et al. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum 2008;58:3765-3775.
27. Seki Y, Kai H, Shibata R, Nagata T, Yasukawa H, Yoshimura A et al. Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ Res 2000;87: 12-18. (Pubitemid 30456929)
28. Gharavi NM, Alva JA, Mouillesseaux KP, Lai C, Yeh M, Yeung W et al. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholi-pids in vitro and in atherosclerosis in vivo. J Biol Chem 2007;282:31460-31468. (Pubitemid 350044874)
29. Recinos A 3rd, LeJeune WS, Sun H, Lee CY, Tieu BC, Lu M et al. Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice. Atherosclerosis 2007;194:125-133. (Pubitemid 47464314)
30. Cuaz-Perolin C, Billiet L, Baugé E, Copin C, Scott-Algara D, Genze F et al. Antiinflam-matory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE2/2 mice. Arterioscler Thromb Vasc Biol 2008;28:272-277. (Pubitemid 351161199)
31. Yoshimura S, Morishita R, Hayashi K, Yamamoto K, Nakagami H, Kaneda Y et al. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy. Gene Ther 2001;8:1635-1642. (Pubitemid 33085585)
32. Yenari MA, Liu J, Zheng Z, Vexler ZS, Lee JE, Giffard RG. Antiapoptotic and Anti-inflammatory Mechanisms of Heat-Shock Protein Protection. Ann N Y Acad Sci 2005;1053:74-83. (Pubitemid 43031084)
33. House SD, Guidon PT Jr, Perdrizet GA, Rewinski M, Kyriakos R, Bockman RS et al. Effects of heat shock, stannous chloride, and gallium nitrate on the rat inflammatory response. Cell Stress Chaperones 2001;6:164-171. (Pubitemid 32522223)
34. Zheng Z, Kim JY, Ma H, Lee JE, Yenari MA. Anti-inflammatory effects of the 70 kDa heat shock protein in experimental stroke. J Cereb Blood Flow Metab 2008;28:53-63.
35. Tanaka K, Namba T, Arai Y, Fujimoto M, Adachi H, Sobue G et al. Genetic evidence for a protective role for heat shock factor 1 and heat shock protein 70 against colitis. J Biol Chem 2007;282:23240-23252. (Pubitemid 47311960)
36. Smith V, Sausville EA, Camalier RF, Fiebig HH, Burger AM. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on HSP90 and client proteins in melanoma models. Cancer Chemother Pharmacol 2005;56:126-137. (Pubitemid 40884268)
37. Herbst M, Wanker EE. Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy. Neurodegener Dis 2007;4:254-260. (Pubitemid 47000417)